BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 36189252)

  • 41. Novel use of the BD FACS SPA to automate custom monoclonal antibody panel preparations for immunophenotyping.
    Kelliher AS; Parent DW; Anderson DC; Dorn ME; Hahn JL; Eapen S; Preffer FI
    Cytometry B Clin Cytom; 2005 Jul; 66(1):40-5. PubMed ID: 15918157
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of delayed sample handling and type of anticoagulant on the interpretation of dysplastic signs detected by flow cytometry.
    Kárai B; Miltényi Z; Gergely L; Száraz-Széles M; Kappelmayer J; Hevessy Z
    Biochem Med (Zagreb); 2018 Jun; 28(2):020704. PubMed ID: 29666557
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The CLEC12A receptor marks human basophils: Potential implications for minimal residual disease detection in acute myeloid leukemia.
    Toft-Petersen M; Stidsholt Roug A; Plesner T; Ebbesen L; Brown GD; Nederby L
    Cytometry B Clin Cytom; 2018 May; 94(3):520-526. PubMed ID: 28718199
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Identification and enumeration of dendritic cells in peripheral blood and bone marrow of healthy individuals].
    Wang DX; Lin HR; Wang YZ; Chang Y; Hao L; Liu YR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1255-60. PubMed ID: 19840462
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of Pre-Analytical and Analytical Variables Associated with Sample Preparation on Flow Cytometric Stainings Obtained with EuroFlow Panels.
    Sędek Ł; Flores-Montero J; van der Sluijs A; Kulis J; Te Marvelde J; Philippé J; Böttcher S; Bitter M; Caetano J; van der Velden VHJ; Sonneveld E; Buracchi C; Santos AH; Lima M; Szczepański T; van Dongen JJM; Orfao A
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158741
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An Italian national multicenter study for the definition of reference ranges for normal values of peripheral blood lymphocyte subsets in healthy adults.
    Santagostino A; Garbaccio G; Pistorio A; Bolis V; Camisasca G; Pagliaro P; Girotto M
    Haematologica; 1999 Jun; 84(6):499-504. PubMed ID: 10366792
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Three-color versus four-color multiparameter cell cycle analyses of primary acute myeloid leukemia samples.
    Garrido SM; Willman C; Appelbaum FR; Banker DE
    Cytometry; 2000 Apr; 42(2):83-94. PubMed ID: 10797445
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Using Full-Spectrum Flow Cytometry to Phenotype Memory T and NKT Cell Subsets with Optimized Tissue-Specific Preparation Protocols.
    Farrand K; Holz LE; Ferrer-Font L; Wilson MD; Ganley M; Minnell JJ; Tang CW; Painter GF; Heath WR; Hermans IF; Burn OK
    Curr Protoc; 2022 Jul; 2(7):e482. PubMed ID: 35819836
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
    Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H
    Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer.
    Almand B; Clark JI; Nikitina E; van Beynen J; English NR; Knight SC; Carbone DP; Gabrilovich DI
    J Immunol; 2001 Jan; 166(1):678-89. PubMed ID: 11123353
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Automated flow cytometry enables high performance point-of-care analysis of leukocyte phenotypes.
    Spijkerman R; Hesselink L; Hellebrekers P; Vrisekoop N; Hietbrink F; Leenen LPH; Koenderman L
    J Immunol Methods; 2019 Nov; 474():112646. PubMed ID: 31419409
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma.
    Flores-Montero J; Sanoja-Flores L; Paiva B; Puig N; García-Sánchez O; Böttcher S; van der Velden VHJ; Pérez-Morán JJ; Vidriales MB; García-Sanz R; Jimenez C; González M; Martínez-López J; Corral-Mateos A; Grigore GE; Fluxá R; Pontes R; Caetano J; Sedek L; Del Cañizo MC; Bladé J; Lahuerta JJ; Aguilar C; Bárez A; García-Mateo A; Labrador J; Leoz P; Aguilera-Sanz C; San-Miguel J; Mateos MV; Durie B; van Dongen JJM; Orfao A
    Leukemia; 2017 Oct; 31(10):2094-2103. PubMed ID: 28104919
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A method for identification and analysis of non-overlapping myeloid immunophenotypes in humans.
    Gustafson MP; Lin Y; Maas ML; Van Keulen VP; Johnston PB; Peikert T; Gastineau DA; Dietz AB
    PLoS One; 2015; 10(3):e0121546. PubMed ID: 25799053
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Method validation and reference range values for a peripheral blood immunophenotyping assay in non-human primates.
    Caldwell RG; Marshall P; Fishel J
    J Immunotoxicol; 2016; 13(1):64-76. PubMed ID: 25600312
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preparation of myeloid derived suppressor cells (MDSC) from naive and pancreatic tumor-bearing mice using flow cytometry and automated magnetic activated cell sorting (AutoMACS).
    Nelson N; Szekeres K; Cooper D; Ghansah T
    J Vis Exp; 2012 Jun; (64):e3875. PubMed ID: 22733203
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Semi-automated Approach to Preparing Antibody Cocktails for Immunophenotypic Analysis of Human Peripheral Blood.
    Koguchi Y; Gonzalez IL; Meeuwsen TL; Miller WL; Haley DP; Tanibata-Branham AN; Bahjat KS
    J Vis Exp; 2016 Feb; (108):e53485. PubMed ID: 26890325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Standardized high-dimensional spectral cytometry protocol and panels for whole blood immune phenotyping in clinical and translational studies.
    Dott T; Culina S; Chemali R; Mansour CA; Dubois F; Jagla B; Doisne JM; Rogge L; Huetz F; Jönsson F; Commere PH; Di Santo J; Terrier B; Quintana-Murci L; Duffy D; Hasan M;
    Cytometry A; 2024 Feb; 105(2):124-138. PubMed ID: 37751141
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of the new Beckman Coulter Cytomics FC 500 5-color flow cytometer on a regional flow cytometry clinical laboratory service.
    Luider J; Cyfra M; Johnson P; Auer I
    Lab Hematol; 2004; 10(2):102-8. PubMed ID: 15224766
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Flow Cytometry Immunophenotyping for Diagnostic Orientation and Classification of Pediatric Cancer Based on the EuroFlow Solid Tumor Orientation Tube (STOT).
    Ferreira-Facio CS; Botafogo V; Ferrão PM; Canellas MC; Milito CB; Romano S; Lopes DV; Teixeira LC; Oliveira E; Bruno-Riscarolli E; Mello FV; Siqueira PFR; Moura P; Macedo FN; Forny DN; Simião L; Pureza AL; Land MGP; Pedreira CE; Dongen JJMV; Orfao A; Costa ESD
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638431
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Flow cytometric analysis of inflammatory and resident myeloid populations in mouse ocular inflammatory models.
    Liyanage SE; Gardner PJ; Ribeiro J; Cristante E; Sampson RD; Luhmann UF; Ali RR; Bainbridge JW
    Exp Eye Res; 2016 Oct; 151():160-70. PubMed ID: 27544307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.